Try a single issue or save on a subscription Issues delivered straight to your door or device ...

Sleep apnea affects millions of people worldwide and prevents them from getting quality sleep. It negatively affects patients ...

The Food and Drug Administration on Friday approved Eli Lilly’s weight-loss drug Zepbound to treat sleep apnea, a common but ...

Popular Eli Lilly weight-loss drug Zepbound can be covered by Medicare plans to treat sleep apnea after it received Food and ...

Studies show that snoring is a common sleep issue faced by around 37 million Americans regularly. While there may be a host ...

The Food and Drug Administration on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and obesity. Zepbound is the first medication approved ...

Researchers, including experts from the University of Missouri School of Medicine, explored the use of senolytics—drugs ...

A Center for Eye Research Australia study has linked low levels of oxygen in the blood overnight—a common sign of obstructive sleep apnea—with wet age-related macular degeneration. Continuous ...

The Food and Drug Administration approved Zepbound as the first prescription medicine to treat sleep apnea on Friday—marking a significant win for the drug company Eli Lilly, which had Zepbound ...

The FDA also recommends that prescribed users reduce their caloric intake and increase their exercise Charna Flam is a writer-reporter at PEOPLE. She has been working at PEOPLE since 2023.

I took his advice, saw a doctor and got tested. I had sleep apnea – and an explanation for years of rough sleeping, headaches and caffeine dependency. For me, treatment has been a game changer. There ...